NEA/SEN/HLGMR(2019)2

At the request of its member countries, the NEA became involved in global efforts to ensure an economically sustainable secure supply of molybdenum-99/technetium-99m. This final ...

This workbook has been developed to aid reactor and alternative technology operators identify their full costs associated with the provision of irradiation services for 99Mo production. The workbook ...

This document provides guidance to reactor and alternative production technology (e.g., cyclotrons, accelerators) operators on how to undertake full-cost identification and implement full-cost recove...

Radioisotopes are an important part of modern medical practice to help diagnose and treat serious health conditions, such as heart disease and cancer. A reliable and cost-effective supply is importan...

The NEA established the High-level Group on the Security of Supply of Medical Radioisotopes (HLG-MR) in April 2009 to examine the underlying reasons for the global 2009-10 supply shortage and to deve...

The use of medical radioisotopes is an important part of modern medical practice. Many millions of patients around the world benefit from nuclear medicine imaging.

The NEA hosted a webinar on 18 November to launch and discuss the findings from its new report The Supply of Medical Radioisotopes: An Economic Diagnosis and Possible Solutions. 

Technetium‑99m (Tc‑99m) is the most commonly used radioisotope in nuclear medicine diagnostic scans. It is essential for diagnostic scans of a broad range of body parts, and thus for accurate diagnos...